ABPro Bio Co Ltd
KOSDAQ:195990
Balance Sheet
Balance Sheet Decomposition
ABPro Bio Co Ltd
ABPro Bio Co Ltd
Balance Sheet
ABPro Bio Co Ltd
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
16 936
|
29 264
|
27 540
|
4 720
|
21 062
|
4 245
|
7 030
|
14 957
|
26 840
|
53 961
|
16 951
|
18 856
|
15 495
|
|
| Cash |
0
|
4
|
18
|
18
|
9
|
8
|
52
|
13
|
1
|
7
|
14
|
8
|
7
|
|
| Cash Equivalents |
16 936
|
29 260
|
27 522
|
4 702
|
21 053
|
4 237
|
6 978
|
14 944
|
26 839
|
53 954
|
16 938
|
18 848
|
15 488
|
|
| Short-Term Investments |
401
|
0
|
3 000
|
55 371
|
31 642
|
3 308
|
0
|
10
|
4 045
|
0
|
4 087
|
72
|
5 743
|
|
| Total Receivables |
6 203
|
4 983
|
25 492
|
15 109
|
20 571
|
21 650
|
19 875
|
10 765
|
5 013
|
4 331
|
4 554
|
6 113
|
12 389
|
|
| Accounts Receivables |
6 203
|
4 291
|
25 339
|
15 069
|
15 387
|
17 236
|
11 970
|
4 208
|
4 126
|
2 781
|
3 237
|
4 035
|
10 005
|
|
| Other Receivables |
0
|
692
|
153
|
40
|
5 184
|
4 414
|
7 905
|
6 557
|
887
|
1 550
|
1 316
|
2 079
|
2 384
|
|
| Inventory |
9 105
|
14 338
|
18 646
|
24 452
|
26 730
|
27 058
|
25 187
|
16 886
|
12 664
|
15 189
|
18 610
|
16 432
|
13 534
|
|
| Other Current Assets |
436
|
909
|
11 313
|
1 876
|
3 604
|
14 410
|
7 533
|
38 806
|
9 246
|
8 422
|
1 591
|
3 330
|
1 820
|
|
| Total Current Assets |
33 081
|
49 494
|
85 991
|
101 527
|
103 609
|
70 671
|
59 625
|
81 426
|
57 808
|
81 903
|
45 793
|
44 804
|
48 981
|
|
| PP&E Net |
14 531
|
14 218
|
30 632
|
31 390
|
30 913
|
59 136
|
53 259
|
49 738
|
39 552
|
24 170
|
23 099
|
22 579
|
21 574
|
|
| PP&E Gross |
0
|
14 218
|
30 632
|
31 390
|
30 913
|
59 136
|
53 259
|
49 738
|
39 552
|
24 170
|
23 099
|
22 579
|
21 574
|
|
| Accumulated Depreciation |
0
|
4 264
|
2 926
|
4 321
|
5 889
|
9 407
|
12 906
|
11 931
|
17 886
|
13 368
|
14 210
|
15 056
|
8 297
|
|
| Intangible Assets |
185
|
247
|
170
|
470
|
629
|
436
|
7 460
|
5 242
|
500
|
3 621
|
2 388
|
3 482
|
3 338
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
8 594
|
14 602
|
6 873
|
0
|
0
|
0
|
8 004
|
13 496
|
|
| Note Receivable |
0
|
315
|
212
|
174
|
254
|
295
|
1 203
|
385
|
256
|
33
|
4 841
|
3 952
|
7 873
|
|
| Long-Term Investments |
474
|
580
|
1 069
|
2 164
|
28 582
|
27 986
|
34 285
|
52 667
|
61 656
|
57 305
|
79 769
|
56 410
|
43 492
|
|
| Other Long-Term Assets |
851
|
828
|
1 332
|
1 301
|
2 434
|
4 811
|
6 037
|
6 540
|
6 256
|
852
|
756
|
2 879
|
2 510
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
8 594
|
14 602
|
6 873
|
0
|
0
|
0
|
8 004
|
13 496
|
|
| Total Assets |
49 122
N/A
|
65 682
+34%
|
119 407
+82%
|
137 027
+15%
|
166 421
+21%
|
171 929
+3%
|
176 471
+3%
|
202 871
+15%
|
166 028
-18%
|
167 884
+1%
|
156 646
-7%
|
142 110
-9%
|
141 263
-1%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
7 373
|
10 301
|
15 982
|
2 204
|
8 182
|
6 138
|
2 457
|
1 346
|
2 227
|
2 911
|
1 559
|
2 127
|
6 855
|
|
| Accrued Liabilities |
0
|
917
|
930
|
814
|
779
|
983
|
2 125
|
2 067
|
2 258
|
479
|
860
|
1 024
|
772
|
|
| Short-Term Debt |
0
|
0
|
5 658
|
2 708
|
6 064
|
10 797
|
5 745
|
2 601
|
2 495
|
0
|
0
|
1 975
|
3 040
|
|
| Current Portion of Long-Term Debt |
3 549
|
11 536
|
0
|
0
|
26 065
|
36 677
|
38 922
|
24 459
|
196
|
21 228
|
10 499
|
7 975
|
7 050
|
|
| Other Current Liabilities |
3 018
|
786
|
6 442
|
2 804
|
4 876
|
7 536
|
3 575
|
33 793
|
7 656
|
5 143
|
3 091
|
4 824
|
3 298
|
|
| Total Current Liabilities |
13 940
|
23 540
|
29 013
|
8 530
|
45 967
|
62 131
|
52 824
|
64 265
|
14 831
|
29 760
|
16 009
|
17 925
|
21 015
|
|
| Long-Term Debt |
275
|
0
|
22 429
|
22 429
|
5 720
|
6 449
|
4 191
|
14 387
|
8 705
|
583
|
441
|
1 844
|
11 963
|
|
| Deferred Income Tax |
1 339
|
1 461
|
1 174
|
2 225
|
89
|
607
|
2 000
|
1 071
|
0
|
0
|
0
|
0
|
213
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
4 572
|
4 433
|
10 221
|
1 743
|
902
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
418
|
675
|
357
|
3 960
|
4 294
|
0
|
0
|
0
|
60
|
|
| Total Liabilities |
15 553
N/A
|
25 001
+61%
|
52 616
+110%
|
33 184
-37%
|
56 765
+71%
|
74 294
+31%
|
69 593
-6%
|
85 426
+23%
|
26 928
-68%
|
30 343
+13%
|
16 450
-46%
|
19 769
+20%
|
33 251
+68%
|
|
| Equity | ||||||||||||||
| Common Stock |
3 930
|
3 930
|
4 914
|
11 549
|
36 747
|
36 894
|
49 231
|
88 382
|
125 735
|
130 102
|
136 845
|
142 345
|
142 345
|
|
| Retained Earnings |
32 612
|
36 446
|
48 485
|
60 065
|
56 849
|
45 251
|
33 941
|
9 920
|
68 918
|
79 070
|
87 193
|
112 935
|
128 564
|
|
| Additional Paid In Capital |
0
|
3 221
|
13 541
|
31 933
|
15 949
|
16 522
|
25 628
|
39 398
|
84 005
|
85 635
|
87 288
|
89 116
|
89 786
|
|
| Unrealized Security Profit/Loss |
0
|
11
|
20
|
31
|
310
|
0
|
736
|
47
|
287
|
1 292
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Other Equity |
2 974
|
2 927
|
168
|
265
|
199
|
1 029
|
1 183
|
365
|
2 006
|
2 169
|
3 259
|
3 817
|
4 448
|
|
| Total Equity |
33 569
N/A
|
40 681
+21%
|
66 791
+64%
|
103 843
+55%
|
109 656
+6%
|
97 635
-11%
|
106 878
+9%
|
117 445
+10%
|
139 100
+18%
|
137 541
-1%
|
140 196
+2%
|
122 340
-13%
|
108 012
-12%
|
|
| Total Liabilities & Equity |
49 122
N/A
|
65 682
+34%
|
119 407
+82%
|
137 027
+15%
|
166 421
+21%
|
171 929
+3%
|
176 471
+3%
|
202 871
+15%
|
166 028
-18%
|
167 884
+1%
|
156 646
-7%
|
142 110
-9%
|
141 263
-1%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
47
|
47
|
52
|
69
|
73
|
74
|
98
|
177
|
251
|
260
|
274
|
285
|
285
|
|
| Preferred Shares Outstanding |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|